Dear Editor,
We read with interest the article by Somaily et al.[1] entitled “Etiological background of osteoporosis in Khamis Mushait General Hospital: A descriptive study assessing risk factors, symptoms, and complications,” published in the Journal of Family Medicine and Primary Care. The authors address an important and often under-recognized public health concern in Saudi Arabia by examining the clinical profile and risk factor distribution among osteoporotic patients in a secondary care setting.
Osteoporosis remains a major contributor to morbidity, disability, and healthcare expenditure worldwide, particularly among aging populations.[2] In Saudi Arabia, demographic transitions toward an older population, combined with lifestyle and comorbidity patterns, are expected to substantially increase the burden of osteoporotic fractures.[3] In this context, region-specific data such as those presented in the current study are essential for informing preventive and clinical strategies at the primary care level.
The predominance of osteoporosis among women over 60 years of age reported in this study is consistent with global epidemiological trends and reinforces the central role of aging and postmenopausal status in bone health deterioration.[4,5] The identification of steroid use and rheumatoid arthritis as prominent associated risk factors further highlights the contribution of secondary osteoporosis in routine clinical practice.[6] These findings point to the importance of proactive risk assessment among patients receiving long-term corticosteroid therapy or managing chronic inflammatory disorders.
An important observation from the study is the high proportion of patients presenting either with bone pain or remaining asymptomatic, alongside a relatively low frequency of documented fractures and complications. This pattern emphasizes the silent nature of osteoporosis and the potential for delayed diagnosis until clinical symptoms emerge. The reported variability in vitamin D and calcium levels also reflects the multifactorial nature of osteoporosis and suggests the need for comprehensive metabolic evaluation as part of routine assessment, particularly in older adults.[7,8,9]
From a primary care and public health perspective, the findings reinforce the need for structured screening approaches, early identification of high-risk individuals, and strengthened awareness programs targeting both healthcare providers and patients. Integrating osteoporosis risk evaluation into routine chronic disease management, especially for elderly women and patients with rheumatologic conditions, may help reduce future fracture burden and associated healthcare costs.
In conclusion, this study contributes valuable regional insight into the etiological background and clinical characteristics of osteoporosis in Southern Saudi Arabia. Continued efforts focusing on early detection, secondary prevention, and patient education are essential to mitigate the growing impact of osteoporosis. Further multicenter research may help refine preventive strategies and support the development of context-specific clinical pathways for osteoporosis management.
Conflicts of interest
There are no conflicts of interest.
Funding Statement
Nil.
References
- 1.Somaily M, Almajadiah S, Yousif S, Alqhtani AM, Alahmari ZK, Alasiri NA, et al. Etiological background of osteoporosis in Khamis Mushait general hospital: A descriptive study assessing risk factors, symptoms, and complications. J Family Med Prim Care. 2025;14:4996–5001. doi: 10.4103/jfmpc.jfmpc_1863_24. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Salari N, Ghasemi H, Mohammadi L, Behzadi MH, Rabieenia E, Shohaimi S, et al. The global prevalence of osteoporosis in the world: A comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2021;16:609. doi: 10.1186/s13018-021-02772-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Aziziyeh R, Garcia Perlaza J, Saleem N, Sadat-Ali M, Elsalmawy A, McTavish RK, et al. The burden of osteoporosis in Saudi Arabia: A scorecard and economic model. J Med Econ. 2020;23:767–75. doi: 10.1080/13696998.2020.1737536. [DOI] [PubMed] [Google Scholar]
- 4.Li M, Yu B, Yang H, He H, Li N, Lv A, et al. Trends and hotspots in research on osteoporosis and nutrition from 2004 to 2024: A bibliometric analysis. J Health Popul Nutr. 2024;43:204. doi: 10.1186/s41043-024-00690-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Özmen S, Kurt S, Timur HT, Yavuz O, Kula H, Demir AY, et al. Prevalence and risk factors of osteoporosis: A cross-sectional study in a tertiary center. Medicina. 2024;60:2109. doi: 10.3390/medicina60122109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Aitella E, Azzellino G, Romano C, Ginaldi L, De Martinis M. Rheumatoid arthritis and osteoporosis as prototypes of immunosenescence in osteoimmunology: Molecular pathways of inflammaging and targeted therapies. Int J Mol Sci. 2025;26:9268. doi: 10.3390/ijms26199268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, et al. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33:2049–102. doi: 10.1007/s00198-021-05900-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Aibar-Almazán A, Voltes Martínez A, Castellote Caballero Y, Afanador Restrepo DF, Carcelén-Fraile MD, López-Ruiz E. Current status of the diagnosis and management of osteoporosis. Int J Mol Sci. 2022;23:9465. doi: 10.3390/ijms23169465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Voulgaridou G, Papadopoulou SK, Detopoulou P, Tsoumana D, Giaginis C, Kondyli FS, et al. Vitamin D and calcium in osteoporosis, and the role of bone turnover markers: A narrative review of recent data from RCTs. Diseases. 2023;11:29. doi: 10.3390/diseases11010029. [DOI] [PMC free article] [PubMed] [Google Scholar]